Serum is used as an additive in the preparation of human spermatozoa for fertilization in vitro, as it is superior to other body fluids in supporting sperm motility. We recently purified the major sperm activating macromolecule present in serum and showed it to be a complex of immunoglobulin and apolipoprotein A-I. This complex, which we named sperm activating protein (SPAP), has now been further characterized using partial proteolysis in combination with different immunological methods. SPAP was shown to interact only with antibodies against immunoglobulin G and more specifically with those against IgG4. The bacterial expression products C23 and ZZ-T (which bind to specific sites on the IgG molecule) bound in similar ways to SPAP as to IgG4 and did not hinder proteolytic cleavage of SPAP, indicating that apolipoprotein A-I is not bound closely to the binding sites of these proteins. Purified F(abЈ) 2 fragment from SPAP was also shown to contain apolipoprotein A-I, and had a higher MW than the corresponding fragment from IgG4. Taken together, the most plausible (and in our view only possible) structure of SPAP shows an apolipoprotein A-I molecule bound in the pocket formed between the Fab arms of an IgG4 molecule. Anti-SPAP antibodies visualized by secondary fluorescein isothiocyanate (FITC)-labelled antibodies were bound to the postacrosomal part of the spermatozoa, indicating that SPAP is specifically bound to this area, and directly interacts with the spermatozoa. Based on these and earlier experiments it is speculated that SPAP acts in the lower part of the female genital tract. The benefit of SPAP should be at its greatest in these regions, and it is also possible that SPAP exerts a selection mechanism, as those spermatozoa affected by SPAP acquire increased motility, which might be important in order to reach the upper part of the female genital tract. Further exploration of the biological role of SPAP may indicate its diagnostic and therapeutic possibilities.
Introduction
to increase the motility of Percoll-separated spermatozoa to the same extent as serum, and polyclonal antibodies against Fertilization in humans usually takes place in the outer part SPAP inhibited sperm motility. of the Fallopian tubes. During the passage through the cervix, In order to explore the potential role of this complex uterus and Fallopian tubes sperm motility must be preserved in diagnosis and therapeutical use, we have now further (Clermont, 1966; Austin, 1985) . The motility is influenced by characterized its structure. the milieu, and can be changed from immotility to hyperactivation. However, despite the importance of the milieu little is known about how different endogenous compounds present in
Materials and methods
the fluids of the female genital tract affect sperm motility and fecundity.
Model for sperm motility test
Serum has for a long time been known to support sperm Semen samples motility and is therefore used in connection with sperm Ejaculates were collected from donors and patients attending the Centre for Reproductive Medicine at the Karolinska Hospital, Stockseparation prior to fertilization in vitro. In order to characterize holm, Sweden. Only samples classified as normal by World Health the most important factors that effect sperm motility in Organization (WHO, 1992 ) criteria (Ͼ20ϫ10 6 cells/ml, Ͼ50% motile) extracellular fluids we fractionated serum, and found that the were used for these experiments. Separation of motile spermatozoa major sperm activating capacity is mediated by a specific was achieved by self-migration using a Percoll gradient technique fraction with a molecular mass~250 kDa (Åkerlöf et al., 1987, followed by translocation of spermatozoa to a defined culture medium 1989). This complex, which we tentatively named sperm (Åkerlöf et al., 1987) . One ml of the ejaculate was layered gently on activating protein (SPAP), was purified and shown to consist top of a discontinuous Percoll gradient. After 3 h at 37°C (without of apolipoprotein A-I and immunoglobulin (Åkerlöf et al., centrifugation) , the upper part was discarded, and the lower 3 ml was recovered (Åkerlöf et al., 1987) . These fractions were added to a 1991; Pousette et al., 1993) . Purified SPAP was shown in vitro pump-filter system (Åkerlöf et al., 1987) apo A-I were purchased from Diagnostika (Falkenberg, Sweden) and After dilution to~20-50ϫ10 6 spermatozoa/ml, aliquots of 0.2 ml Calbiochem. Ten monoclonal antibodies directed against various were transferred to separate tubes and preparations to be tested were epitopes on apo A-I (AI-4, AI-7, AI-9, AI-10, AI-11, AI-14, AI-15, added. All experiments were performed in duplicate, and included AI-16, and AI-18) were obtained from Dr L.K.Curtiss (Scripps Clinic appropriate controls.
and Research Foundation, La Jolla, USA) (Curtiss and Edgington, Serum from three male donors (used as control and for purification 1985; Curtiss, 1988; Hogle et al., 1988) . Horseradish peroxidase of SPAP), were incubated at 56°C for 30 min and stored at -20°C (HRP) and fluorescein isothiocyanate (FITC)-labelled conjugated goat until used. SPAP was purified as described below and bovine serum anti-mouse and anti-rabbit antibodies (used as secondary antibodies) albumin (BSA; A-4378, Sigma) was dissolved in, or transferred to, were purchased from Dakopatts. buffer A before use.
Bacterial expression products C23 and ZZ-T and their interaction with SPAP and IgG4 Studies of the structure of sperm activating protein
The bacterial expression products C23 and ZZ-T were obtained from Purification of SPAP Dr Roland Andersson (Karolinska Institute, Stockholm, Sweden). SPAP was essentially purified as earlier described (Åkerlöf et al., These are constructs which bind to specific epitopes on immuno-1991). Serum (100 ml) was fractionated on a 100 ml DEAEglobulins (Ahlborg et al., 1994) (Figure 4 ). The C23 protein was Sepharose column (Pharmacia Fine Chemicals, Uppsala, Sweden) radio-labelled with 125 I using the method described by Bolton and equilibrated in 0.01 M phosphate buffer, pH 7.4. After washing, a Hunter (1973) . The ZZ-T protein was also radio-labelled using the linear gradient of 2ϫ300 ml 0-0.25 M NaCl in 0.01 M phosphate chloramine-T method (Hunter and Greenwood, 1962) . In order to buffer, pH 7.4, was applied. Fractions (~5 ml) able to promote sperm study the interaction of specific binding sites blocked with 3% BSA (in PBS). The pieces The pooled fractions were added to a Blue Sepharose column were then incubated overnight at room temperature [ 125 I]-ZZ-T, rinsed (10ϫ20 mm) (Pharmacia) equilibrated in 0.125 M phosphate buffer, in PBS, and the radioactivity measured. pH 7.4. The sperm activating capacity did not adhere to the gel and Formation of SPAP complex in vitro was recovered in the fractions corresponding to the void volume and IgG4 and apo A-I were incubated together in order to analyse the a wash with 0.125 M phosphate buffer, pH 7.4 (total: 30 ml). This formation of SPAP in vitro. Equal concentrations of IgG4κ (The material was lyophilized and routinely dissolved in 1.0 ml water.
Binding Site Ltd) and apo A-I (Sigma) were incubated at 20, 30, 37 Purification of F(abЈ) 2 from SPAP and 50°C for 1, 2 or 6 h. The resulting mixture was then analysed Purified SPAP (500 µg) was digested with pepsin according to the by SDS-PAGE under non-reducing conditions which are appropriate manufacturer's instructions (Pierce, Rockford, IL, USA) to cleave off for the detection of SPAP. the intact F(abЈ) 2 from SPAP (4 h at 37°C). The F(abЈ) 2 was then Anti-SPAP binding to spermatozoa separated from partially digested Fc by allowing Fc fragments to Spermatozoa were separated by swim-up (Earle's medium, 13% bind to a Protein A Sepharose column (5 ml) (Pierce), and the nonserum) and were allowed to dry on slides overnight. Since they had bound fraction consisting of intact F(abЈ) 2 and small fragments of Fc been separated from seminal plasma in a medium containing serum was then dialysed overnight at 4°C using a 50 kDa cut-off dialysis they were assumed to have been exposed to SPAP. All further membrane. The solution was then lyophilized and redissolved in incubations were for 30 min, at room temperature. The slides were 0.5 ml H 2 O. After determination of the protein concentration, the incubated in anti-SPAP serum diluted 1:100 or, as a control, without identity of the purified F(abЈ) 2 was verified by sodium dodecyl anti-SPAP serum. After washing, the slides were incubated with sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis FITC-labelled anti-rabbit IgG serum (The Binding Site Ltd), at a (reducing and non-reducing conditions). The F(abЈ) 2 purified from concentration of 1:10 for 1h at room temperature. The slides were SPAP was analysed for the presence of apo A-I by both dot blot and examined microscopically at a magnification of ϫ100-250. Western blot analysis.
Antibodies
Analytical methods Polyclonal antibodies against SPAP were generated as described Radioimmunological tests by Åkerlöf et al. (1991) . Polyclonal antibodies against different [ 125 I]-SPAP was incubated overnight with the different antibodies to immunoglobulin classes (IgG, IgA, IgE, IgD and IgM) and against be tested (Åkerlöf et al., 1991) . Immunoprecipitation was performed immunoglobulin light chains (κ and λ) were purchased from Dakopatts by addition of a secondary antibody and the radioactivity of the (Glostrup, Denmark). Monoclonal antibodies against different subprecipitate was measured using a γ counter. Decanting suspensions 2 classes of immunoglobulin G (IgG1, IgG2, IgG3 and IgG4) and against different parts of immunoglobulin (Fc and Fab) were purchased and 3 (Pharmacia) were used as precipitating solutions for polyclonal antibodies and Immunobeads 170-5104 (Bio-Rad, Richmond, USA) were used to precipitate monoclonal antibodies.
Dot tests
Dot tests were performed using subclass-specific anti-IgG antibodies. The protein to be analysed was applied to a nitrocellulose paper strip and, after blocking with 3% gelatine, was incubated with antibodies. After washing the binding was visualized by means of a HRPconjugated secondary antibody.
Electrophoresis SDS-PAGE was performed using PAA 4/30 (Pharmacia) gels or Mini-Protean II Ready Gels (4-20%) (Bio-Rad). Electrophoresis was performed according to the recommendations of the manufacturers, except that the sample buffer used with the Bio-Rad system was 5ϫ concentration, as described by Bollag and Edelstein (1991) .
Western blots
Western blots of the SPAP complex were performed following protein separation on reduced or non-reduced SDS-PAGE gels. Proteins were Figure 1 . Western blot analysis of controls, sperm activating transferred to Hybond-C nitrocellulose paper (0.45 µm) (Amersham, protein (SPAP) and Fab fragments. Following sodium dodecyl UK) using the Bio-Rad Mini-Protean Transfer Cell in the buffer sulphate-polyacrylamide gel electrophoresis (SDS-PAGE; reducing system described by Towbin et al. (1979) , at 30 V and 40-90 mA conditions) proteins were transferred and incubated with antiovernight, at 4°C. The unoccupied sites were blocked using either apolipoprotein A-I (Calbiochem 178 474) and visualized by 3% BSA or gelatine (both in PBS). Blots were then incubated with horseradish peroxidase (HRP) reagents. The molecular weight primary and secondary antibodies and developed using a horseradish standards are biotinylated, and avidin-HRP was added to the peroxidase-developing kit (Bio-Rad). Biotinylated molecular weight secondary antibody. Note that since the samples were reduced all standards were visualized using an avidin-HRP-linked secondary subunits have dissociated. HMW ϭ high molecular weight antibody.
standards (Bio-Rad); LMW ϭ low molecular weight standards (Bio-Rad); F(abЈ) 2 ϭ 3 mg of F(abЈ) fragment purified from SPAP; Partial proteolysis was carried out by incubating purified SPAP SPAP ϭ 3 mg of SPAP; apo A-I ϭ 3 mg of apolipoprotein A-I. and controls (IgG4κ, IgG4λ and apo A-I) with pepsin (Boehringer Mannheim 108 057) in a 1:100 enzyme to protein ratio, using the conditions described by Turner and Bennich (1970) . The resultant hinge region. After partial proteolysis of SPAP with pepsin, digests were analysed with SDS-PAGE, using both reducing and non-reducing conditions.
the Fab product has a molecular weight slightly higher than the corresponding product obtained from IgG4 (data not shown).
Protein estimation
Following proteolysis of SPAP with pepsin and purification Quantification of total protein was performed with the Bradford assay of intact F(abЈ) 2 , both dot test and Western blot analysis of (Bio-Rad Laboratories, Münich, Germany) using BSA or IgG4 as these F(abЈ) 2 fragments of SPAP proved them to contain apo standard, as appropriate.
A-I (Figure 1) .
[ 125 I]-labelled protein C23 and protein ZZ-T were able to bind to both SPAP and IgG4. Using increasing concentrations
Results
of labelled protein, binding curves were obtained which were Purification of SPAP similar for SPAP and IgG4 (Figure 2a,b) . SPAP was purified to homogeneity using a four-step procedure.
Formation of SPAP did not appear to occur in vitro. CoStarting with 100 ml serum containing~5 g of total protein, incubation of apo A-I and IgG4 under a variety of conditions 50 µg (10-250 µg, n ϭ 15) pure SPAP was recovered. All failed to induce the appearence of a band with a molecular preparations induced increased sperm motility, validated as weight of~180 kDa, corresponding to SPAP. earlier described (Åkerlöf et al. 1991) and showed a protein band at~180 kDa when analysed by SDS-PAGE using nonAnti-SPAP binding to spermatozoa reducing conditions. Spermatozoa incubated with anti-SPAP and second FITClabelled antiserum showed (in all studies) a distinct band of Studies on structure of sperm activating protein fluorescence at the post-acrosomal region. In some studies a When analysed in dot tests, purified SPAP interacted with slight fluorescence was also visible at the lower region of the specific antiserum against IgG but not with antisera against sperm head. This fluorescence was not visible when anti-SPAP IgA, IgD or IgE. Further similar experiments showed interwas omitted (Figure 3 ). actions with antiserum against IgG4 but not with antisera against IgG1, IgG2 or IgG3. Polyclonal antisera raised against apo A-I interacted with both reduced and non-reduced SPAP.
Discussion
None of the 14 tested monoclonal anti apo A-l antisera reacted Structure of SPAP with non-reduced SPAP, but all reacted with reduced SPAP.
SPAP could be cleaved with pepsin in a similar way to The structure of SPAP has been partially resolved. The most plausible structure shows an apolipoprotein A-I molecule cleavage of IgG4, indicating that apo A-I is not bound in the Fluorescein isothiocyanate (FITC)-anti-sperm activating protein (SPAP)-labelled spermatozoa. Spermatozoa were prepared as described in the text and were allowed to dry on slides overnight. The slides were incubated in anti-SPAP serum diluted 1:100. After washing, the slides were incubated with FITC-labelled anti-rabbit immunoglobulin G serum and examined at ϫ100-250 magnification.
bound in the pocket formed between the Fab arms of an IgG4 in the hinge region. Therefore, these experiments exclude binding of apo A-I either to the hinge region or to part of the molecule (Figure 4) .
The immunological studies strongly indicate that the Fc-region. That the apolipoprotein A-I molecule is bound to the Fab immunoglobulin moiety consists of IgG4, which suggests a level of specificity as only~7% of serum immunoglobulin is moiety is shown both by the fact that purified Fab from SPAP contains apolipoprotein AI and that this fragment has a higher IgG4. No differences could be detected when comparing IgG4λ and IgG4κ which indicates that the light chain is non-specific. molecular weight than the corresponding fragment from IgG4. The fact that under non-reducing conditions, no monoclonal As no difference was found when comparing the binding of the [ 125 I]-labelled proteins C23 and ZZ-T to SPAP and anti-apolipoprotein A-I antibody was bound to SPAP indicates that this molecule is either well hidden or is transformed when IgG4, it is reasonable to assume that the apolipoprotein A-I molecule does not bind in the same area as these proteins. As it is bound to IgG4. Taken together, the most plausible structure for SPAP is proteolytic cleavage of SPAP amd IgG4 was also similar, this indicates that the apolipoprotein A-I molecule does not bind that of an apolipoprotein A-I molecule bound in the pocket sperm motility during their voyage through the female genital tract. In recent papers γ-aminobutyric acid (Calogero et al., 1996) , progesterone (Yang et al., 1994) , and a number of different substances which act via creatinine kinase (Yeung et al., 1996) have been shown to increase sperm motility. Most probably a number of factors influence sperm motility and we feel that further research is important as the more information we have about these factors, the better we can select spermatozoa for assisted fertilization or develop strategies for male anticonception drugs.
